Vitamin D Therapy Market
  • Published Date: Aug-2021
  • |
  • 180 Pages
  • |
  • Report ID: HE0086

Vitamin D Therapy Market

The Vitamin D Therapy Market is expected to grow from USD 2.01 billion in 2019 to USD 4.52 billion by 2026 at a CAGR of 12.29% from 2019 to 2026.

  • Report Description
  • Table of Content
  • Segmentation
  • Companies
  • News

Vitamins are a set of organic compounds that are fundamentals for the normal and healthy development of body. Vitamin D is a fat-soluble vitamin that is contemporary in very few foods. It is formed endogenously in the human body when ultraviolet rays from sunlight raid the skin and activate vitamin D synthesis. Vitamin D aids in the process of calcium absorption in the gut and maintains adequate calcium and phosphate attentions to allow normal mineralization of bone. Vitamin D deficiency primes to rickets, a disease in which the bone tissue doesn't properly mineralize, leading to soft bones and skeletal deformities. But gradually, research is revealing the importance of vitamin D in protecting against a host of health problems. increase in awareness about vitamin D deficiency, the surge in levels of malnutrition, rise in patient compliance to oral medications, increase in the frequency of hypovitaminosis D, aging population, sedentary lifestyles, and lack of exposure to the sun. The global market is segregated on the basis of Application as Muscle Weakness, Autoimmune Disorders, Other Applications, Osteoporosis, Rickets, and Skin Diseases. Based on Age Group the global market is segmented in Adults, Senior Adults, and Children. Based on Purchasing Pattern the global market is segmented in Prescription Drugs and OTC Drugs. Based on Route of Administration, the global market is segmented in Parenteral Route and Oral Route.

The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Sanofi, Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Cadila Healthcare Ltd, Novartis AG, Pfizer Inc, GlaxoSmithKline PLC, Merck & Co., Inc., Abbott, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Vitamin D Therapy market has been segmented as below:

By Application

  • Muscle Weakness
  • Autoimmune Disorders
  • Other Applications
  • Osteoporosis
  • Rickets
  • Skin Diseases

By Age Group

  • Adults
  • Senior Adults
  • Children

By Purchasing Pattern

  • Prescription Drugs
  • OTC Drugs

By Route of Administration

  • Parenteral Route
  • Oral Route

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

By Company

  • Sanofi
  • Torrent Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Cadila Healthcare Ltd
  • Novartis AG
  • Pfizer Inc
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Abbott

The report covers the below scope:

  • Global market sizes from 2020 to 2026, along with CAGR for 2020-2026
  • Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2022 to 2026
  • Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year - 2022
  • Forecast period - 2022 to 2026

Report Scope:

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Sanofi, Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Cadila Healthcare Ltd, Novartis AG, Pfizer Inc, GlaxoSmithKline PLC, Merck & Co., Inc., Abbott, and others.

Why Buy this Report:

  • Gain detailed insights on the Vitamin D Therapy industry trends
  • Find a complete analysis of the market status
  • Identify the market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

                        4.2.2 Restraints

                        4.2.3 Opportunities

                        4.2.4 Challenges

            4.2 Porter's Five Force Analysis

  1. By Application

            5.1 Introduction

            5.2 Muscle Weakness

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Autoimmune Disorders

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

            5.4 Other Applications

                        5.4.1 Market Overview

                        5.4.2 Market Size and Forecast

            5.5 Osteoporosis

                        5.5.1 Market Overview

                        5.5.2 Market Size and Forecast

            5.6 Rickets

                        5.6.1 Market Overview

                        5.6.2 Market Size and Forecast

            5.7 Skin Diseases

                        5.7.1 Market Overview

                        5.7.2 Market Size and Forecast

  1. By Age Group

            6.1 Introduction

            6.2 Adults

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Senior Adults

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

            6.4 Children

                        6.4.1 Market Overview

                        6.4.2 Market Size and Forecast

  1. By Purchasing Pattern

            7.1 Introduction

            7.2 Prescription Drugs

                        7.2.1 Market Overview

                        7.2.2 Market Size and Forecast

            7.3 OTC Drugs

                        7.3.1 Market Overview

                        7.3.2 Market Size and Forecast

  1. By Route of Administration

            8.1 Introduction

            8.2 Parenteral Route

                        8.2.1 Market Overview

                        8.2.2 Market Size and Forecast

            8.3 Oral Route

                        8.3.1 Market Overview

                        8.3.2 Market Size and Forecast

  1. By Geography

            9.1 Introduction

            9.2 Europe

                        9.2.1 Europe Market, By Application

                        9.2.2 Europe Market, By Age Group

                        9.2.3 Europe Market, By Purchasing Pattern

                        9.2.4 Europe Market, By Route of Administration

            9.3 North America

                        9.3.1 North America Market, By Application

                        9.3.2 North America Market, By Age Group

                        9.3.3 North America Market, By Purchasing Pattern

                        9.3.4 North America Market, By Route of Administration

            9.4 Asia Pacific

                        9.4.1 Asia Pacific Market, By Application

                        9.4.2 Asia Pacific Market, By Age Group

                        9.4.3 Asia Pacific Market, By Purchasing Pattern

                        9.4.4 Asia Pacific Market, By Route of Administration

            9.5 Rest of The World

                        9.5.1 Rest of The World Market, By Application

                        9.5.2 Rest of The World Market, By Age Group

                        9.5.3 Rest of The World Market, By Purchasing Pattern

                        9.5.4 Rest of The World Market, By Route of Administration

  1. Competitive Insights

            10.1 Key Insights

            10.2 Company Market Share Analysis

            10.3 Strategic Outlook

                        10.3.1 Mergers & Acquisitions

                        10.3.2 New Product Development

                        10.3.3 Portfolio/Production Capacity Expansions

                        10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        10.3.5 Others

  1. Company Profiles

            11.1 Sanofi

                        11.1.1 Company Overview

                        11.1.2 Product/Service Landscape

                        11.1.3 Financial Overview

                        11.1.4 Recent Developments

            11.2 Torrent Pharmaceuticals Ltd.

                        11.2.1 Company Overview

                        11.2.2 Product/Service Landscape

                        11.2.3 Financial Overview

                        11.2.4 Recent Developments

            11.3 Sun Pharmaceutical Industries Ltd.

                        11.3.1 Company Overview

                        11.3.2 Product/Service Landscape

                        11.3.3 Financial Overview

                        11.3.4 Recent Developments

            11.4 Alkem Laboratories Ltd.

                        11.4.1 Company Overview

                        11.4.2 Product/Service Landscape

                        11.4.3 Financial Overview

                        11.4.4 Recent Developments

            11.5 Cadila Healthcare Ltd

                        11.5.1 Company Overview

                        11.5.2 Product/Service Landscape

                        11.5.3 Financial Overview

                        11.5.4 Recent Developments

            11.6 Novartis AG

                        11.6.1 Company Overview

                        11.6.2 Product/Service Landscape

                        11.6.3 Financial Overview

                        11.6.4 Recent Developments

            11.7 Pfizer Inc

                        11.7.1 Company Overview

                        11.7.2 Product/Service Landscape

                        11.7.3 Financial Overview

                        11.7.4 Recent Developments

            11.8 GlaxoSmithKline PLC

                        11.8.1 Company Overview

                        11.8.2 Product/Service Landscape

                        11.8.3 Financial Overview

                        11.8.4 Recent Developments

            11.9 Merck & Co., Inc.

             &

By Application

  • Muscle Weakness
  • Autoimmune Disorders
  • Other Applications
  • Osteoporosis
  • Rickets
  • Skin Diseases

By Age Group

  • Adults
  • Senior Adults
  • Children

By Purchasing Pattern

  • Prescription Drugs
  • OTC Drugs

By Route of Administration

  • Parenteral Route
  • Oral Route

  • Sanofi
  • Torrent Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Cadila Healthcare Ltd
  • Novartis AG
  • Pfizer Inc
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Abbott

License Options

  • Single 1500 USD
  • Multiple 3000 USD